Viewing Study NCT04439266


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2025-12-28 @ 6:11 PM
Study NCT ID: NCT04439266
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2020-06-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-08-12
Start Date Type: ACTUAL
Primary Completion Date: 2020-03-20
Primary Completion Date Type: ACTUAL
Completion Date: 2026-03-17
Completion Date Type: ESTIMATED
First Submit Date: 2020-06-18
First Submit QC Date: None
Study First Post Date: 2020-06-19
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-07-14
Results First Submit QC Date: None
Results First Post Date: 2022-09-22
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-06
Last Update Post Date: 2025-11-19
Last Update Post Date Type: ESTIMATED